The UK Liver Alliance is calling for liver disease to be a health priority

February 20, 2023

The UK Liver Alliance has written to the Secretary of State for Health, Steve Barclay, calling for liver disease to be appropriately recognised in policy initiatives, plans and strategies. The UK Liver Alliance is a coalition of more than 30 organisations, who are committed to improving liver health.

Following Steve Barclay’s recent Written Statement to the House, announcing the new Major Conditions Strategy, the UK Liver Alliance raised concerns around the omission of liver disease in the statement and more widely in the Department’s policy approach.

Historically liver disease has not been appropriately included in initiatives around noncommunicable diseases and is often omitted from Department of Health policy to address public health challenges.

Up to 1 in 5 people are affected by non-alcohol related fatty liver disease (NAFLD) in the UK. The Office for Health Improvements and Disparities reports that liver disease and liver cancer caused 2.5% of deaths in England in 2020. Almost half of these deaths occur in people of working age (ages 15 to 64). Liver disease has increased by 400% since the 1970s, driven by a range of factors including overweight and obesity.

Pamela Healy OBE, Chair of the UK Liver Alliance said

“Liver disease needs to be pushed up the Department for Health’s policy priority list. For too long it has been stigmatised and omitted from plans and initiatives.

This sends a terrible message to the NHS, Integrated Care Boards and GPs, around the importance of liver disease. We urgently need greater GP awareness around liver disease and better early diagnosis, treatment and care for patients.

The UK Liver Alliance will continue to promote the prioritisation of liver disease with the Secretary of State for Health, until we have the policies in place to properly manage liver disease and to start to improve care and outcomes for liver disease patients.”

The UK Liver Alliance have asked Department of Health officials to look at how the Department can meaningfully include liver disease in its policy work and specifically how it can be addressed in the Major Conditions Strategy.

Click here to read the full letter.

More news

Potential for hundreds more liver transplants after NICE recommends new life-saving liver procedure for NHS use

Potential for hundreds more liver transplants after NICE recommends new life-saving liver procedure for NHS use

The British Liver Trust welcomes the news that hundreds more liver transplants could be carried out after a new procedure that supplies a donor liver with oxygen before removal was approved by NICE for use in the NHS.   In-situ ...
New hope for people living with MASH as two treatments receive MHRA approval

New hope for people living with MASH as two treatments receive MHRA approval

People living with metabolic dysfunction-associated steatohepatitis (MASH) have received encouraging news, with the UK medicines regulator approving two treatments for the condition within the past month. The Medicines and Healthcare ...
New Lancet Commission Highlights the Vital Role of Primary Care in Tackling Liver Disease

New Lancet Commission Highlights the Vital Role of Primary Care in Tackling Liver Disease

A major new Lancet Gastroenterology & Hepatology Commission, published today, has shone a spotlight on the crucial role that primary care can play in preventing, detecting and managing liver disease. We were proud to contribute to ...
No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.